{
    "2021-06-02": [
        [
            {
                "time": "2023-10-15",
                "original_text": "Senate Finance Committee launches probe into AbbVie's tax practices",
                "features": {
                    "keywords": [
                        "Senate",
                        "Finance",
                        "Committee",
                        "probe",
                        "AbbVie",
                        "tax",
                        "practices"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false"
                }
            },
            {
                "time": "2023-10-15",
                "original_text": "AbbVie's Rinvoq Shows Encouraging Long Term Safety, Efficacy In Rheumatoid Arthritis, Psoriatic Arthritis Patients",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "Rinvoq",
                        "Encouraging",
                        "Long",
                        "Term",
                        "Safety",
                        "Efficacy",
                        "Rheumatoid",
                        "Arthritis",
                        "Psoriatic",
                        "Arthritis"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-15",
                "original_text": "AbbVie to Present at the Goldman Sachs 42nd Annual Global Healthcare Conference",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "Goldman",
                        "Sachs",
                        "Annual",
                        "Global",
                        "Healthcare",
                        "Conference"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-15",
                "original_text": "Phase 3 Maintenance Results Show Patients with Crohn's Disease Receiving Risankizumab (SKYRIZI®) Achieved Endoscopic Response and Clinical Remission at One Year",
                "features": {
                    "keywords": [
                        "Phase",
                        "3",
                        "Maintenance",
                        "Results",
                        "Patients",
                        "Crohn's",
                        "Disease",
                        "Risankizumab",
                        "SKYRIZI®",
                        "Endoscopic",
                        "Response",
                        "Clinical",
                        "Remission",
                        "One",
                        "Year"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-15",
                "original_text": "AbbVie to Present Analysis Evaluating Continuous RINVOQ® (upadacitinib) Treatment in Psoriatic Arthritis for More Than One Year at EULAR 2021 Virtual Congress",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "Present",
                        "Analysis",
                        "Evaluating",
                        "Continuous",
                        "RINVOQ®",
                        "upadacitinib",
                        "Treatment",
                        "Psoriatic",
                        "Arthritis",
                        "EULAR",
                        "2021",
                        "Virtual",
                        "Congress"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-15",
                "original_text": "AbbVie Faces U.S. Senate Pressure Over Tax Payments",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "U.S.",
                        "Senate",
                        "Pressure",
                        "Tax",
                        "Payments"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false"
                }
            },
            {
                "time": "2023-10-15",
                "original_text": "New Long-Term Efficacy and Safety Analyses Evaluating RINVOQ® (upadacitinib) in Patients with Rheumatoid Arthritis to be Presented at EULAR 2021 Virtual Congress",
                "features": {
                    "keywords": [
                        "Long-Term",
                        "Efficacy",
                        "Safety",
                        "Analyses",
                        "Evaluating",
                        "RINVOQ®",
                        "upadacitinib",
                        "Patients",
                        "Rheumatoid",
                        "Arthritis",
                        "EULAR",
                        "2021",
                        "Virtual",
                        "Congress"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-15",
                "original_text": "15 Most Valuable Pharmaceutical Companies In The World",
                "features": {
                    "keywords": [
                        "15",
                        "Most",
                        "Valuable",
                        "Pharmaceutical",
                        "Companies",
                        "World"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}